SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen Matthews who wrote (1818)12/6/1996 5:48:00 PM
From: Mark Chavez   of 2281
 
A company lower in value than ADVR but currently in phase III trials is Alfacell (ACEL), now listed on Nasdaq. You can get details in its section. Another biotech in the news is Ligand Pharmaceuticals (LGND), and Immune Response (IMNR) may be a sleeper. BTW, it took ACEL several years to get their product from in vitro studies to where they are now, so a lot of patience may be necessary in regards to ADVR. R&D doesn't happen overnight in biotech, one of its problems. We'll see how Hirschman does at the wheel. Good luck.

Mark.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News